Propyliodone

Summary

Propyliodone (CHEMBL1200821) is an approved small molecule (ATC V08AD03).

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• ATC class: V08AD03
• Chemistry: 447.01 Da · C10H11I2NO3

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL1200821
Name	Propyliodone
Type	Small molecule
Max phase	4
FDA approved	no
PubChem CID	4949
ATC	V08AD03
Molecular formula	C10H11I2NO3
Molecular weight	447.01
InChIKey	ROSXARVHJNYYDO-UHFFFAOYSA-N

SMILES: CCCOC(=O)CN1C=C(C(=O)C(=C1)I)I

IUPAC name: propyl 2-(3,5-diiodo-4-oxo-1-pyridinyl)acetate

Also known as: Dionosil aqueous, Dionosil oily, NSC-97103, Propiliodona, Propyliodone, Propyliodonum, PROPYLIODONE

Patent coverage: 302 distinct patent families (1,193 SureChEMBL compound mentions), from 1 matched compound structure(s). Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).